| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8719468 | The Journal of Emergency Medicine | 2018 | 4 Pages |
Abstract
Intravenous ascorbic acid appears to be a potential alternative to methylene blue in this patient population. The data surrounding teratogenicity of methylene blue are mostly related to intra-amniotic or intra-uterine administration. In life-threatening cases of methemoglobinemia during pregnancy, the benefits of i.v. methylene blue may outweigh the risks.
Related Topics
Health Sciences
Medicine and Dentistry
Emergency Medicine
Authors
Andrew C. PharmD, BCPS, Emily PharmD, BCPS, Nidhu PharmD, Anthony MD,